Beacon Datastore
AI-powered platform for storing, integrating, and analyzing biosignal data
Platform · Cloud SaaSCompany source
Company profile
About Beacon Biosignals
Beacon Biosignals is a precision medicine company transforming brain health through AI-driven neurotechnology. The company operates a comprehensive platform that collects, integrates, and analyzes neurophysiological and cardiopulmonary data to accelerate drug development and enable scalable home sleep testing diagnostics. Beacon's technology serves two primary markets: life sciences companies conducting clinical trials and research, and healthcare providers delivering at-home sleep diagnostics. The platform centers on the FDA 510(k)-cleared Waveband EEG headband (formerly Dreem 3S), which collects clinical-grade sleep staging data equivalent to polysomnography in patients' natural environments. Data is securely uploaded to the Beacon Datastore, where advanced AI and machine learning algorithms characterize patient-level and population-level brain function. The company supports pharmaceutical companies throughout Phase 1-4 drug development with comprehensive clinical study operations and scientific services. For healthcare providers, Beacon offers scalable at-home sleep testing solutions including Sleepview Direct and the SleepView Monitor. The company is building the world's largest clinically validated neurophysiology dataset, having analyzed over 2 million hours of EEG data, supported 40+ clinical trials, and completed 500,000+ home sleep tests. Beacon's mission is to transform treatment for patients from clinical development to clinical practice, enabling life-changing therapies to reach the right patients faster through precision neuroscience.
Company description Beacon Biosignals official website
Primary marketPrecision Medicine & Genomics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Beacon Biosignals?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- brain health
- hypersomnia conditions
- neurological conditions
- sleep disorders
Who it serves
- Biotechnology companies
- Health systems
- Neurologists
- Pharmaceutical companies
- Primary care providers
- Sleep physicians
Deployment & integration
Cloud Saas · Embedded · Other deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
Company milestones
Platform expansion
Series B financing upsized to over $97 million (April 2026), Named in Fast Company's Most Innovative Companies of 2026 (March 2026), Partnership with Harmony Biosciences announced (December 2025)
Partnerships
Recorded partners
- Harmony Biosciences
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Beacon HQ
Centralized analytics and trial management portal for clinical development teams
Platform · Cloud SaaSCompany source
Clinical Study Operations
End-to-end support for clinical trials from deployment to data quality review
Service · OtherCompany source
Scientific Services
Expert analysis and interpretation of clinical-grade EEG data for drug development
Service · OtherCompany source
Sleepview Direct
At-home sleep testing solution for sleep physicians and primary care
Platform · Cloud SaaSCompany source
SleepView Monitor
Home sleep testing device for clinical practice
Device · EmbeddedCompany source
Waveband
FDA 510(k)-cleared EEG headband for at-home clinical-grade brain data collection
Device · EmbeddedCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Toward unified and comprehensive automated electroencephalogram interpretation: a multicentre development and validation of an electroencephalogram foundation model.The Lancet. Digital health · Aug 25, 2026
To what extent do pragmatic cues from disfluencies inform our predictions of spoken language during naturalistic language processing?Cortex; a journal devoted to the study of the nervous system and behavior · Aug 1, 2026
At-home EEG-based sleep monitoring in people living with Lennox-Gastaut syndrome: The HEADFIRST study.Epilepsy & behavior : E&B · Jul 9, 2026
The Insomnia EEG Score: a new tool for the classification of people with poor sleep.Sleep · Apr 16, 2026
Multicenter evaluation of the Waveband System for automated sleep assessment in patients with insomnia symptoms.Sleep · Mar 28, 2026
Similar destabilization of neural dynamics under different general anesthetics.Cell reports · Mar 24, 2026
Clinical validation
Clinical-trial records
Deep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's DiseaseNCT07110376 · Sponsor · RECRUITING
Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of NarcolepsyNCT06531876 · Sponsor · COMPLETED
Validation and Usability Study of the SleepView+ Home Sleep Testing System for the Evaluation of Moderate to Severe Obstructive Sleep Apnea.NCT07476313 · Sponsor · ENROLLING BY INVITATION
Regulatory
Regulatory records
Dreem 3SK242094 · 510k · Nov 22, 2024
SleepStageMLK233438 · 510k · Mar 8, 2024
Dreem 3SK223539 · 510k · Aug 18, 2023
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
2M+ hours of EEG analyzed
Total EEG data processed through the Beacon Platform
40+ clinical trials supported
Clinical trials using Beacon's platform for drug development
500K+ home sleep tests completed
At-home sleep diagnostics delivered
Harmony Biosciences
Incorporating quantitative EEG measurements into two Phase 3 studies of HBS-301 for Narcolepsy and Idiopathic Hypersomnia to assess excessive daytime sleepiness with objective sleep data alongside patient-reported outcomes
Advancing objective clinical endpoints in hypersomnia conditions through quantitative EEG, complementing traditional patient-reported outcomes like Epworth Sleepiness Scale
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
David Matthews
President of Life Sciences
06 · Company updates
Updates from Beacon Biosignals
Recent articles published on Beacon Biosignals's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Precision Medicine & Genomics
Companies using AI to analyze genomic, proteomic, metabolomic, or multi-omics data to provide personalized treatment recommendations, identify genetic risks, or develop targeted therapies. Includes genomic sequencing platforms with AI analysis, preventive medicine based on genetic risk assessment, and longevity care based on molecular and genetic data.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.